Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.
Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.
As part of this report's coverage, the following data is included:
The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.
As part of Kalorama Information's comprehensive coverage of Point of Care Diagnostics the following companies are discussed:
Related Reports:Mergers and Acquisitions in the IVD Market
Feb 17, 2015 - KLI5470884 - $500.00
Global Orthopedic Device Market (Hip, Knee, Spine, Extremities and Trauma Devices)
Feb 10, 2015 - KLI5467092 - $3,500.00
The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)
Jan 31, 2015 - KLI5464816 - $4,995.00
Abbott Diagnostics: Company Profile
Jan 21, 2015 - KLI5442542 - $500.00
Roche Diagnostics: Company Profile
Jan 21, 2015 - KLI5442543 - $500.00
Siemens Healthcare: Company Profile
Jan 21, 2015 - KLI5442544 - $500.00
IVD Procedure Volumes and Pricing Analysis
Jan 14, 2015 - KLI5440452 - $3,995.00
Ultrasound: World Market Analysis
Dec 17, 2014 - KLI5416203 - $1,500.00
The World Market for Veterinary Diagnostics
Dec 5, 2014 - KLI5399100 - $3,500.00
CT Systems: World Market Analysis
Dec 1, 2014 - KLI5393134 - $1,995.00
Questions?Contact a research specialist >
Most Popular ResearchThe Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition The United States Market for In Vitro Diagnostic Tests The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Retail Clinics Market Overview and 2014 Survey Results Bioinformatics in IVD Testing The Market and Potential for Molecular Point of Care Diagnostics